Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set

Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy

(2018) Foucauld Chamming’s et al.   RADIOLOGY

Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients

(2017) Ming Fan et al.   EUROPEAN JOURNAL OF RADIOLOGY

Effects of MRI scanner parameters on breast cancer radiomics

(2017) Ashirbani Saha et al.   EXPERT SYSTEMS WITH APPLICATIONS

Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI

(2016) Alina Tudorica et al.   Translational Oncology

Texture analysis on MR images helps predicting non-response to NAC in breast cancer

(2015) N. Michoux et al.   BMC CANCER

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?

(2015) Helena Earl et al.   BMC Medicine

Computer-aided breast MR image feature analysis for prediction of tumor response to chemotherapy

(2015) Faranak Aghaei et al.   MEDICAL PHYSICS

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer

(2013) Xiaosong Chen et al.   BREAST CANCER RESEARCH AND TREATMENT

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

(2013) André Robidoux et al.   LANCET ONCOLOGY

Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial

(2013) Aman U Buzdar et al.   LANCET ONCOLOGY

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

(2012) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Texture analysis in assessment and prediction of chemotherapy response in breast cancer

(2012) Arfan Ahmed et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial

(2012) Michael Untch et al.   LANCET ONCOLOGY

Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

(2010) Line Nilsen et al.   ACTA ONCOLOGICA

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

(2010) A. Fangberget et al.   EUROPEAN RADIOLOGY

Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy

(2010) Takayoshi Uematsu et al.   EUROPEAN RADIOLOGY

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

(2010) Luca Gianni et al.   LANCET

DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: A pilot study

(2009) Oana I. Craciunescu et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

(2009) Reiki Nishimura et al.   Breast Cancer

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy

(2008) Martin D. Pickles et al.   EUROPEAN JOURNAL OF RADIOLOGY

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

(2008) Uma Sharma et al.   NMR IN BIOMEDICINE